TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $8,303,000 | -22.1% | 609,195 | -6.4% | 0.64% | -32.0% |
| Q3 2021 | $10,663,000 | -47.8% | 650,995 | -46.4% | 0.94% | -38.3% |
| Q2 2021 | $20,443,000 | -54.6% | 1,214,695 | -50.8% | 1.53% | -53.9% |
| Q1 2021 | $45,078,000 | -13.7% | 2,468,695 | -14.0% | 3.31% | -11.1% |
| Q4 2020 | $52,259,000 | +11.2% | 2,871,395 | +9.0% | 3.72% | +9.0% |
| Q3 2020 | $46,978,000 | -22.1% | 2,633,295 | -21.7% | 3.42% | +0.8% |
| Q2 2020 | $60,278,000 | +11.2% | 3,361,876 | -5.9% | 3.39% | +11.4% |
| Q1 2020 | $54,209,000 | -17.9% | 3,571,076 | +6.7% | 3.04% | +19.4% |
| Q4 2019 | $66,016,000 | +21.8% | 3,345,976 | +6.1% | 2.55% | +27.3% |
| Q3 2019 | $54,222,000 | +55.1% | 3,152,470 | +59.6% | 2.00% | +63.9% |
| Q2 2019 | $34,964,000 | +8.8% | 1,975,360 | +25.2% | 1.22% | +14.8% |
| Q1 2019 | $32,143,000 | – | 1,577,960 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |